Study #2023-0047
Long-term safety follow up protocol for HLA-G-Targeted CAR T-Cell therapy in subjects with previously treated advanced HLA-G-Positive tumors
MD Anderson Study Status
Enrolling
Treatment Agent
Description
Long-term safety follow up protocol for HLA-G-Targeted CAR T-Cell therapy in subjects with HLA-G+
Resources and Links
Phone Number: 1-877-MDA-6789
clinicaltrials.gov NCT No: N/A
Information and next steps
Disease:
Anus;Bones and Joints;Breast;Cervix;Colon;Corpus Uteri;Esophagus;Kaposi's Sarcoma;Kidney;Larynx;Lip, Oral Cavity and Pharynx;Liver;Lung;Melanoma, Skin;Other Digestive Organ;Other Endocrine System;Other Female Genital;Other Male Genital;Other Respiratory and Intrathoracic Organs;Other Skin;Other Urinary;Ovary;Pancreas;Prostate;Rectum;Small Intestine;Soft Tissue;Stomach;Thyroid
Study phase:
Phase I/II
Physician name:
Aung Naing
Department:
Investigational Cancer Therapeutics
For general questions about clinical trials:
1-844-580-2777
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.